These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1300451)

  • 1. Recombinant human erythropoietin treatment may induce antithrombin-III depletion.
    Arinsoy T; Ozdemir O; Arik N; Ozcebe O; Yasavul U; Dündar S; Turgan C; Kirazli S; Cağlar S
    Nephron; 1992; 62(4):480-1. PubMed ID: 1300451
    [No Abstract]   [Full Text] [Related]  

  • 2. [Two new drugs. Recombinant "human" erythropoietin (EPO: Erypo, Recormon)].
    Verwiebe R
    Internist (Berl); 1992 Apr; 33(4):279-81. PubMed ID: 1612854
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein C, protein S and antithrombin III metabolism in dialysis patients.
    Lai KN
    Int J Artif Organs; 1993 Jan; 16(1):4-6. PubMed ID: 8458670
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Yin JA; Li PK; Yuen PM; Lui SF
    Int J Artif Organs; 1992 May; 15(5):264-8. PubMed ID: 1601509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human recombinant erythropoietin on plasminogen activator inhibitor, and protein C and S activity.
    Steffensen G; Aunsholt NA
    Am J Nephrol; 1996; 16(5):453-4. PubMed ID: 8886186
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte indices during treatment with human recombinant erythropoietin in dialysis patients.
    de Jong GM; Kolsters G; Offerman JJ
    Nephrol Dial Transplant; 1990; 5(1):77-8. PubMed ID: 2109289
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hemodialysis on protein C, protein S, and antithrombin III levels.
    Lai KN; Yin JA; Yuen PM; Li PK
    Am J Kidney Dis; 1991 Jan; 17(1):38-42. PubMed ID: 1824735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures in dialysis patients treated with recombinant erythropoietin.
    Beccari M; Romagnoni M; Sorgato G
    Nephrol Dial Transplant; 1995; 10(3):423-4. PubMed ID: 7792048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous reactions to treatment with recombinant human erythropoietin].
    Schröder-Kolb B
    Derm Beruf Umwelt; 1990; 38(1):12-3. PubMed ID: 2139602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
    Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
    Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
    [No Abstract]   [Full Text] [Related]  

  • 12. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hemodialysis and long-term erythropoietin treatment on protein C, and on free and total protein S.
    Clyne N; Egberg N; Lins LE
    Thromb Res; 1995 Oct; 80(2):161-8. PubMed ID: 8588193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G; Kouame C
    Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation.
    Jaar B; Denis A; Viron B; Verdy E; Chamma F; Siohan P; Mignon F
    Am J Nephrol; 1997; 17(5):399-405. PubMed ID: 9382155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of erythropoietin in predialysis patients.
    Anderson S
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin--complications, side effects].
    Koide K; Arai T
    Nihon Rinsho; 1991 Dec; 49 Suppl():679-87. PubMed ID: 1808335
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
    Tomura S
    Nihon Rinsho; 1991 Dec; 49 Suppl():695-701. PubMed ID: 1808338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.